BIOGEN INC. is 23.5x more valuable than Immatics N.V. by market capitalization ($29.53 B vs $1.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMTX | BIIB |
|---|---|---|
| Market cap | $1.26 B | $29.53 B |
| US-listed rank | #2479 | #476 |
| Revenue (latest FY) | - | $9.89B |
| Net income (latest FY) | - | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.8 |
| SEC filings | 220 | 2,690 |
BIOGEN INC. is 23.5x more valuable than Immatics N.V. by market capitalization ($29.53 B vs $1.26 B).
Full pages: Immatics N.V. and BIOGEN INC., or browse the full rankings.